Ebola vaccine trial shows promising results
FT News in Focus - En podcast af Financial Times
Kategorier:
The first Ebola vaccine to be tested on humans, developed by GlaxoSmithKline and the US National Institutes of Health, has shown promising results in early trials, paving the way for it to be tested on healthcare workers in west Africa in the new year. Fiona Symon spoke to Andrew Ward about the potential of the vaccine to address the Ebola crisis Hosted on Acast. See acast.com/privacy for more information.